Select Page ::

Global Nanorobotics Market : Industry Analysis and Forecast (2019-2026) by Type, Application, and… – Azizsalon News

Posted on May 26, 2020 by Prof Baldwin

Global Nanorobotics Marketwas valued at US$ 3.7 Bn in 2018 and is expected to reach US$ 9.2Bn by 2026, at a CAGR of 12.06%during a forecast period.

Developments in nanotechnology coupled with demand for minimally aggressive procedures are expected to drive market growth over the forecast period. Nanobots possess likely in the medical sector for destroying cancerous cells at the genetic level. Increasing support for nanomedicine by many nations and the increasing geriatric population are factors which can augur market demand.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/30888

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Utilization of nanobots in the ranostics can be beneficial for the market in the near future. A rise in miniaturization and demand for automation across various sectors are anticipated to fuel market growth. Training of new personnel to use nanobots can restrain market growth in the upcoming years.Nanomedicine application segment to grow at the highest CAGR during the forecast period. Nanorobotics is widely used in nanomedicine owning to its healthcare features. The large share of this application aspects to the large level of commercialization in the healthcare sector for drug delivery, in vivo imaging, biomaterial, in vitro diagnostic, active implants, and drug therapy.

North America region accounted for the largest share of 12.2%, in terms of value, of the nanorobotics market globally. Presence of many nanotechnology companies, well-developed healthcare infrastructure, and government initiatives to create patient awareness are factors driving the market. The U.S is anticipated to contribute to market revenue owing to the increase in cardiovascular diseases and the rising elderly populace.

Europe follows North America as the second biggest nanorobotics market. Presence of chronic diseases and the burgeoning population are factors expected to indicate the Europe nanobots market. Establishment of organizations to develop standards pertaining to nanotechnology can expand market growth. In 2018, DNA-Robotics, an organization including 12 European companies, has outlined steps to expedite production of nanobots on a large scale. These standards can help scale the market exponentially in the upcoming years.

A recent development in nanorobotics market: In March 2018, Thermo Fisher Scientific acquired Gatan, an exclusively owned subsidiary of Roper Technologies. Gatan is an electron microscopy solutions provider in the U.S, which accompaniments the Thermo Fisher Scientifics electron microscopy solutions business.In March 2017, Oxford Instruments (U.K) Asylum Research introduced its new SurfRider HQ-Series of high quality, budget-priced AFM probes, which are also existing in a model suitable for nanomechanical image mode.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Nanorobotics Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTERs analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Nanorobotics Market.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/30888

Scope of the Global Nanorobotics Market

Global Nanorobotics Market, By Type

Nanomanipulatoro Electron Microscope (EM) Scanning Electron Microscope (SEM) Transmission Electron Microscope (TEM)o Scanning Probe Microscope (SPM) Atomic Force Microscopes (AFM) Scanning Tunneling Microscope (STM) Bio-Nanorobotics Magnetically Guided Bacteria-BasedGlobal Nanorobotics Market, By Application

Nanomedicine Biomedical Mechanical OthersGlobal Nanorobotics Market, By Region

North America Europe Asia Pacific Middle East and Africa South AmericaKey players operating in Global Nanorobotics Market:

Bruker JEOL Thermo Fisher Scientific Ginkgo Bioworks Oxford Instruments EV Group Imina Technologies Toronto Nano Instrumentation KlockeNanotechnik KleindiekNanotechnik Xidex Synthace Park Systems Smaract Nanonics ImagingKey Innovators:

Novascan Technologies Angstrom Advanced Hummingbird Scientific NT-MDT Spectrum Instruments Witec

MAJOR TOC OF THE REPORT

Chapter One: Nanorobotics Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanorobotics Market Competition, by Players

Chapter Four: Global Nanorobotics Market Size by Regions

Chapter Five: North America Nanorobotics Revenue by Countries

Chapter Six: Europe Nanorobotics Revenue by Countries

Chapter Seven: Asia-Pacific Nanorobotics Revenue by Countries

Chapter Eight: South America Nanorobotics Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanorobotics by Countries

Chapter Ten: Global Nanorobotics Market Segment by Type

Chapter Eleven: Global Nanorobotics Market Segment by Application

Chapter Twelve: Global Nanorobotics Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanorobotics Market Report at:https://www.maximizemarketresearch.com/market-report/global-nanorobotics-market/30888/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys – Science Advances

Posted on July 31, 2020 by Prof Baldwin

Cell-free DNA (cfDNA) released from damaged or dead cells combines with LL37 and is converted into an immune response activator to exacerbate psoriasis. Here, we show that cationic nanoparticles (cNPs) efficiently compete for DNA from the DNA-LL37 immunocomplex and inhibit DNA-LL37-induced cell activation. Using phenotypical images, psoriasis area and severity index scoring, histology, and immunohistochemical analysis, we demonstrate that topical application of cNPs on psoriasiform skin of a mouse model relieves psoriatic symptoms. It is noteworthy that the results were confirmed in a cynomolgus monkey model. Moreover, topically administrated cNPs showed low in vivo toxicity because of their retention in skin. Mechanistic analyses of cytokine expression in the psoriatic site, cfDNA levels in circulation and inflamed skin, skin permeation, and biodistribution of cNPs also matched the therapeutic outcomes. Therefore, we present a previously unidentified strategy of nanomedicine to treat skin inflammatory diseases, which demonstrates great potential for clinical application.

Follow this link:
Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys - Science Advances

US Virtual 3D Nanorobots Market 2020: Deep Analysis of Current Trends and Future Demand by Top Key Players are Gingko Bioworks, Synthace, Zymergen…

Posted on December 23, 2020 by Prof Baldwin

Virtual 3D Nanorobots Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025Increasing prevalence of chronic diseases and rising adoption of technologically advanced medical equipments drive the growth of global virtual 3D nanorobots Market.

Get Sample Copy of The Activated Alumina Market Report 2020@ https://brandessenceresearch.com/requestSample/PostId/555

*The sample pages of this report is immediately accessible on-demand.**

Scope of Global Virtual 3D Nanorobots Market Report-

Nanorobots are nano electromechanical systems designed to perform a specific task with precision at nano scale dimensions. It will be mainly used for the treatment in field of nanomedicine. An interesting utilization of nanorobots may be their attachment to transmigrating inflammatory cells or WBC, to reach inflamed tissues and assist in their healing process. It can also used for biomedical instrumentation, early diagnosis and targeted drug delivery for cancer, pharmacokinetics, surgery, monitoring of diabetes and health care. Virtual 3D nanorobots are expected to provide personalized treatments with improved efficacy and reduced side effects that are not available today. Virtual 3D nanorobots can be used to treat genetic diseases by comparing the molecular structures of both DNA and proteins found in the cell to known or desired reference structures. Some of its potential applications are; early diagnosis and targeted drug delivery for cancer biomedical instrumentation, pharmacokinetics, monitoring of diabetes, surgery and others. Another possible application can be the capability to locate atherosclerotic lesions in stenosed blood vessels, particularly in the coronary circulation, and treat them either mechanically, chemically or pharmacologically.

Virtual 3D nanorobots marketreport is segmented on the basis of type, application, distribution channel and region & country level. Based upon type, global virtual 3D nanorobots market is classified into microbivore nanorobots, respirocyte nanorobots, clottocyte nanorobots. Based upon application, global virtual 3D nanorobots market is divided into dentistry, emerging drug delivery, brain aneurysm, cancer detection, gene therapy, nanomedicine, biomedical, healthcare and others.

The regions covered in this Virtual 3D Nanorobots Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Virtual 3D Nanorobots is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Some major key players for Global Virtual 3D Nanorobots Market Gingko Bioworks, Synthace, Zymergen Inc., Advanced Diamond Technologies and Advanced Nano Products Co. Limited and others.

Increasing Prevalence of Chronic Diseases and Rising Adoption of Technologically Advanced Medical Equipments Drive the Growth of Global Virtual 3D Nanorobots Market

Nanorobots are expected to provide new treatments for the patients suffering from different diseases. Latest developments in the field of biomolecular computing have demonstrated the feasibility of processing logic tasks by bio-computers. The major factor driving the growth of global virtual 3D nanorobots market is increasing adoption of technologically advanced products in healthcare coupled with the rising government initiatives in this field. In addition, increasing prevalence of chronic diseases, improving healthcare infrastructure and technological advancements to develop more innovative, better and effective medical treatments are also anticipated to foster the market growth within the forecast period. In recent years, the potential of nanotechnology motivated many governments to devote significant resources to this new field. The U.S. National Science Foundation launched a program in Scientific Visualization in part to harness supercomputers in picturing the nanoworld. Firms such as; IBM, PARC, Hewlett Packard, Bell Laboratories, and Intel Corp. and others are collaborating to produce new nano products.

Cancer can be successfully treated with current stages of medical technologies and therapy tools. One of the important aspect to achieve a successful treatment for cancer patients is the development of efficient targeted drug delivery to decrease the side effects from chemotherapy. Nanorobots can help on such extremely important aspects of cancer therapy owing to the properties of nanorobots to navigate as blood borne devices. Nanorobots with embedded chemical biosensors can be used to perform detection of tumour cells in early stages of development inside the patients body. Thus all these advantages of nanorobots are expected to boost the market growth.

However, lack of trained professional may hamper the market growth. In spite of that, increasing advancements in the field can provide various opportunities for the further growth of the market. The use of nanorobots may advance biomedical intervention with minimally invasive surgeries and help patients who need constant body functions monitoring, or ever improve treatments efficiency through early diagnosis of possible serious diseases.

North America is Expected to Dominate the Global Virtual 3D Nanorobots Market

The global virtual 3D nanorobots market is segmented into North America, Europe, Asia-Pacific Latin America and Middle East & Africa. North America is expected to dominate the global virtual 3D nanorobots market within the forecast period attributed to the highly developed healthcare infrastructure and increasing adoption of new technologies in healthcare in this region. In addition, increasing government initiative in this field are also supplementing the growth of virtual 3D nanorobots market in this region. Asia Pacific is anticipated to witness a significant growth in global Virtual 3D Nanorobots market owing to emerging economies and growing awareness about nanorobotics in healthcare. In addition, improving healthcare infrastructure due to the favourable government initiatives regarding health are also expected to foster the growth of virtual 3D nanorobots market in this region within the forecast period.

Key Benefits for Market Report

Virtual 3D Nanorobots MarketSegmentation:-

By Type: Respirocyte Nanorobots, Microbivore Nanorobots, Clottocyte Nanorobots

By Application:-Dentistry, Gene therapy, Brain Aneurysm, Emerging Drug Delivery, Cancer detection, NanoMedicine, Biomedical, Healthcare, Others

By Regional & Country Analysis

North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

Get Full Report :@ https://brandessenceresearch.com/technology-and-media/virtual-d-nanorobots-market

https://sites.google.com/view/industrytrends/ict-and-media/cyber-security-in-healthcare-market-2020-industry-analysis

https://sites.google.com/view/industrytrends/ict-and-media/data-monetization-market-key-vendors-growth-analysis-revenue-strategies

https://sites.google.com/view/industrytrends/semiconductor-and-electronics/electronic-shelf-label-esl-market-insights-forecasts-to-2025

https://sites.google.com/view/industrytrends/ict-and-media/endpoint-security-market-to-undertake-strapping-growth-by-the-end-2025

https://sites.google.com/view/industrytrends/healthcare-industry-trends/enteral-syringe-market-to-hit-usd-840-2-million-with-a-cagr-of-4-9-2025

https://sites.google.com/view/industrytrends/healthcare-industry-trends/epigenetics-market-size-to-reach-2-83-billion-by-2025

https://teletype.in/@shubhamgosavi/QXRihGbpR

https://teletype.in/@shubhamgosavi/0WtqR9ujr

https://teletype.in/@shubhamgosavi/3M6_tiypz

https://teletype.in/@shubhamgosavi/So4_UMfi2

https://teletype.in/@shubhamgosavi/QUPceMECm

https://teletype.in/@shubhamgosavi/-SkVcnYSW

https://teletype.in/@shubhamgosavi/h-MbmBF30i

https://teletype.in/@shubhamgosavi/UIsVVmi9Z

https://socialmarketingsubmisssion1.blogspot.com/2020/12/chemical-catalyst-market-expected-to.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/contract-research-organization-market.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/cyber-security-in-healthcare-market.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/data-monetization-market-key-vendors.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/electronic-shelf-label-market-size-2020.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/endpoint-security-market-to-undertake.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/enteral-syringe-market-to-hit-usd-8402.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/epigenetics-market-size-to-reach-283.html

About Us:

Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Website:https://brandessenceresearch.com/

Article:https://businessstatsnews.com

Blog:http://www.dailyindustrywatch.com

Blog:https://marketsize.biz

Blog:https://technologyindustrynews.com

Blog:https://marketstatsreport.com

The rest is here:
US Virtual 3D Nanorobots Market 2020: Deep Analysis of Current Trends and Future Demand by Top Key Players are Gingko Bioworks, Synthace, Zymergen...

May 2020 Global Radiocontrast Agent Market Report 2020 COVID 19 Impact Analysis on Key Players GE Healthcare (US), Bracco Imaging (Italy), Bayer…

Posted on May 26, 2020 by Prof Baldwin

The research report on the Radiocontrast Agent market provides a detailed analysis of the market. A detailed analysis of the market is done by covering all the major aspects, which affects the growth of the market. The report on Radiocontrast Agent market also provides a detailed impact of the current trends, such as the corona virus pandemic (COVID-19).

Inquiry For Buying or Customization of Report: @ https://www.cognitivemarketresearch.com/chemical-%26-materials/radiocontrast-agent-market-report#request_sample

Global Radiocontrast Agent market report offers in-depth insights of the supply chain and the strategies for the growth of the Radiocontrast Agent market. The impact of the corona virus on the supply chain is also covered, which is one of the major attributes which affects the Radiocontrast Agent market. The market report on Radiocontrast Agent market also covers a detailed analysis of the growth and the impact of the products which were introduced before the impact of the COVID-19 pandemic. A detailed analysis of the product life cycle is also covered in the Radiocontrast Agent market report. nicolas.shaw@cognitivemarketresearch.com or call us on +1-312-376-8303.

Request a Sample Copy of this report @ https://www.cognitivemarketresearch.com/chemical-%26-materials/radiocontrast-agent-market-report#request_sample

Market Segmentation:Segmentation by Type: Barium-based Radiocontrast Agent, Iodinated Radiocontrast Agent, Gadolinium-based Radiocontrast Agent, Microbubble Radiocontrast Agent, X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound

Segmentation by Application: Radiology, Interventional Radiology, Interventional Cardiology

Segmentation by Key Players:b> GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India)

Download and Access Exclusive Free Sample Report Pages {CoronoVirus Impact Analysis Updated Copy} Click Here> Download Sample Report of Radiocontrast Agent Market Report 2020 (Updated Eidtion May 2020)

Market, By Regions:In addition, Radiocontrast Agent market report categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:North America (the United States, Canada, and Mexico)Europe (Germany, UK, France, Italy, and Russia, etc.)Asia-Pacific (China, Japan, ASEAN, India, and Korea)The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)South America (Brazil, Chile, Peru, and Argentina)

Table of Content : Global Radiocontrast Agent Market Report 2019: Market Size, Status and Forecast Till 2027 Chapter 1. Industry Overview of Global Radiocontrast Agent Chapter 2 Global Radiocontrast Agent Competition Analysis by Players Chapter 3 Company (Top Players) Profiles Chapter 4 Global Radiocontrast Agent Market Size by Type and Application (2014-2019) Chapter 5 Development Status and Outlook Chapter 11 Market Forecast by Regions, Type and Application (2019-2027) Chapter 12 Global Radiocontrast Agent Market Dynamics Chapter 12.1 Global Radiocontrast Agent Industry News 12.2 Global Radiocontrast Agent Industry Development Challenges 12.3 Global Radiocontrast Agent Industry Development Opportunities (2019-2027) Chapter 13 Market Effect Factors Analysis Chapter 14 Global Radiocontrast Agent Market Forecast (2019-2027) Chapter 15 Research Finding/Conclusion Chapter 16 Appendix To check the complete Table of Content click here: @ https://www.cognitivemarketresearch.com/chemical-%26-materials/radiocontrast-agent-market-report#table_of_contents

Thanks for reading this article; Please connect with our sales team, who will ensure that you get a report that suits your needs.

Inquiry For Buying or Customization of Report: @ https://www.cognitivemarketresearch.com/chemical-%26-materials/radiocontrast-agent-market-report#request_sample

About us: http://www.cognitivemarketresearch.com/about-usNicolas Shaw,Sales Manager,Global Business Development,Website: http://www.cognitivemarketresearch.comEmail: nicolas.shaw@cognitivemarketresearch.com or call us on +1-312-376-8303.Address: 20 N State Street, Chicago, Illinois, 60602, United States.

**********Download the Entire Report*************************************************

Read the original:
May 2020 Global Radiocontrast Agent Market Report 2020 COVID 19 Impact Analysis on Key Players GE Healthcare (US), Bracco Imaging (Italy), Bayer...

Global Radiocontrast Agent Market 2020 with Coronavirus/COVID-19 After Effects Analysis by Major Key Players | GE Healthcare (US), Bracco Imaging…

Posted on August 2, 2020 by Prof Baldwin

Global Radiocontrast Agent Market: Past, Current, and Future Market Analysis, Trends, and Opportunities, 2016-2026

The new report published by the Market Research Store global Radiocontrast Agent market is slated for a rapid growth in the coming years. The research study projects that the market is expected to grow at a good CAGR of XX% during the forecast period. The valuation for the Radiocontrast Agent market made by our research analysts is around USD XX Million in 2019 and anticipates USD XX Million by the end of 2026.

Request a sample copy of this report@www.marketresearchstore.com/report/global-radiocontrast-agent-market-report-2018-industry-analysis-383589#RequestSample

The competitive landscape evaluation of the Radiocontrast Agent market players include GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India). The information that is profiled for each of the market player will include their primary foundation business model as well as their current business strategy, SWOT analysis, their market share, revenue, pricing, gross margin , and the recent developments.

Radiocontrast Agent Market Report Insights

Overview of the Radiocontrast Agent market, its scope, and target audience. In-depth description about the market drivers, restraints, future market opportunities, and challenges. Details about the advanced technologies, including big data & analytics, artificial intelligence, and social media platforms used by the global Radiocontrast Agent Market Primary legislations that will have a great impact on the global platform. Comprehensive analysis about the key players in the global Radiocontrast Agent market. Recent developments, mergers and acquisitions, collaborations, R&D projects are mentioned in the Radiocontrast Agent market report.

Read Full Research Report::www.marketresearchstore.com/report/global-radiocontrast-agent-market-report-2018-industry-analysis-383589

Radiocontrast Agent Market Segmentation

Global Radiocontrast Agent market: By Type Analysis

Barium-based Radiocontrast Agent, Iodinated Radiocontrast Agent, Gadolinium-based Radiocontrast Agent, Microbubble Radiocontrast Agent

Global Radiocontrast Agent market: By Application Analysis

Radiology, Interventional Radiology, Interventional Cardiology

Global Radiocontrast Agent market: By Regional Analysis North America Europe Asia Pacific Latin America Middle East and Africa

If Any Inquiry of Radiocontrast Agent Report:www.marketresearchstore.com/report/global-radiocontrast-agent-market-report-2018-industry-analysis-383589#InquiryForBuying

In the segmentation part of the report a thorough research of each and every segment is done. For in-depth information some of the major segments have been segregated into sub-segments. In the regional segmentation also our research analysts have not only concentrated on the major regions but have also included the country-wise analysis of the Radiocontrast Agent market.

See the original post:
Global Radiocontrast Agent Market 2020 with Coronavirus/COVID-19 After Effects Analysis by Major Key Players | GE Healthcare (US), Bracco Imaging...

Healthcare Nanotechnology (Nanomedicine) Market Research Report with Revenue, Gross Margin, Market Share and Future Prospects till 2026 – The Market…

Posted on November 29, 2020 by Prof Baldwin

The Healthcare Nanotechnology (Nanomedicine) Market grew in 2019, as compared to 2018, according to our report, Healthcare Nanotechnology (Nanomedicine) Market is likely to have subdued growth in 2020 due to weak demand on account of reduced industry spending post Covid-19 outbreak. Further, Healthcare Nanotechnology (Nanomedicine) Market will begin picking up momentum gradually from 2021 onwards and grow at a healthy CAGR between 2021-2025

Deep analysis about market status (2016-2019), competition pattern, advantages and disadvantages of products, industry development trends (2019-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to downstream buyers of this industry have been analysed scientifically. This report will help you to establish comprehensive overview of the Healthcare Nanotechnology (Nanomedicine) Market

Get a Sample Copy of the Report at: https://i2iresearch.com/report/global-healthcare-nanotechnology-(nanomedicine)-market-2020-market-size-share-growth-trends-forecast-2025/#download-sample

The Healthcare Nanotechnology (Nanomedicine) Market is analysed based on product types, major applications and key players

Key product type:NanomedicineNano Medical DevicesNano DiagnosisOther

Key applications:AnticancerCNS ProductAnti-infectiveOther

Key players or companies covered are:AmgenTeva PharmaceuticalsAbbottUCBRocheCelgeneSanofiMerck & CoBiogenStrykerGilead SciencesPfizer3M CompanyJohnson & JohnsonSmith & NephewLeadiant BiosciencesKyowa Hakko KirinShireIpsenEndo International

The report provides analysis & data at a regional level (North America, Europe, Asia Pacific, Middle East & Africa , Rest of the world) & Country level (13 key countries The U.S, Canada, Germany, France, UK, Italy, China, Japan, India, Middle East, Africa, South America)

Inquire or share your questions, if any: https://i2iresearch.com/report/global-healthcare-nanotechnology-(nanomedicine)-market-2020-market-size-share-growth-trends-forecast-2025/

Key questions answered in the report:1. What is the current size of the Healthcare Nanotechnology (Nanomedicine) Market, at a global, regional & country level?2. How is the market segmented, who are the key end user segments?3. What are the key drivers, challenges & trends that is likely to impact businesses in the Healthcare Nanotechnology (Nanomedicine) Market?4. What is the likely market forecast & how will be Healthcare Nanotechnology (Nanomedicine) Market impacted?5. What is the competitive landscape, who are the key players?6. What are some of the recent M&A, PE / VC deals that have happened in the Healthcare Nanotechnology (Nanomedicine) Market?

The report also analysis the impact of COVID 19 based on a scenario-based modelling. This provides a clear view of how has COVID impacted the growth cycle & when is the likely recovery of the industry is expected to pre-covid levels.

Contact us:i2iResearch info to intelligenceLocational Office: *India, *United States, *GermanyEmail: [emailprotected]Toll-free: +1-800-419-8865 | Phone: +91 98801 53667

Read the original post:
Healthcare Nanotechnology (Nanomedicine) Market Research Report with Revenue, Gross Margin, Market Share and Future Prospects till 2026 - The Market...

Healthcare Nanotechnology (Nanomedicine) Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And…

Posted on July 13, 2020 by Prof Baldwin

New Jersey, United States,- Latest update on Healthcare Nanotechnology (Nanomedicine) Market Analysis report published with extensive market research, Healthcare Nanotechnology (Nanomedicine) Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Healthcare Nanotechnology (Nanomedicine) industry. With the classified Healthcare Nanotechnology (Nanomedicine) market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Healthcare Nanotechnology (Nanomedicine) market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Healthcare Nanotechnology (Nanomedicine) market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Healthcare Nanotechnology (Nanomedicine) Market growth opportunities in the industry.

Healthcare Nanotechnology (Nanomedicine) Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Healthcare Nanotechnology (Nanomedicine) market size, volume and value, as well as price data.

Healthcare Nanotechnology (Nanomedicine) Market competition by top Manufacturers:

Healthcare Nanotechnology (Nanomedicine) Market Classification by Types:

Healthcare Nanotechnology (Nanomedicine) Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Healthcare Nanotechnology (Nanomedicine) Market Report:

Cataloging the competitive terrain of the Healthcare Nanotechnology (Nanomedicine) market:

Unveiling the geographical penetration of the Healthcare Nanotechnology (Nanomedicine) market:

The report of the Healthcare Nanotechnology (Nanomedicine) market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Healthcare Nanotechnology (Nanomedicine) Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Healthcare Nanotechnology (Nanomedicine) Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Original post:
Healthcare Nanotechnology (Nanomedicine) Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And...

Northern youth group seeks speedy passage of Bill to establish National Innovation agency – Daily Sun

Posted on July 19, 2020 by Prof Baldwin

Sola Ojo, Kaduna

The leadership of Arewa Youth Assembly on Sunday appealed to the leadership of the 9th National Assembly to give speedy passage of the bill to establish a National Innovation Agency (NiNNOVA Establishment Bill 2020) which has already scaled through the first reading early July.

The bill, sponsored by the lawmaker representing Nnewi North/South/Ekwusigo Federal Constituency, Chris Emeka Azubogu, is expected to play a leading role in the development of Nigerias innovation ecosystem by coordinating, networking, fostering, and partnering different organizations from various fields such as academia, technology, industry, finance and investment.

The group in a statement through its Speaker, Mohammed salihu Danlami noted that, the main focus of the agency if established, would be on utilizing knowledge management to achieve innovation, which could be employed as the principal tool in improving quality of life and as a driving tool for an increasingly competitive economy.

According to Mohammed, NiNNOVA would undertake a broad-based and systematic approach in facilitating innovation development in Nigeria, both in terms of making improvements and pioneering new initiatives.

More precisely, NiNNOVA will focus on fostering strategic innovation and industry innovation, which will enhance national productivity, encourage economic restructuring and social development as well as promote national competitiveness by focusing on coordinating industrial clusters both at the policy and operational levels, promoting innovation culture and building up innovation systems, with a broader aim to transform Nigeria into an innovation-driven economy.

The National innovation Agency, if enacted, will coordinate innovation activities as well as administer funding to grow and support the innovation ecosystem and entrepreneurship in Nigeria. It shall exist to promote the development of efficient and innovative Nigerian systems within thematic areas such as technology, ICT, nanomedicine, nanotechnology, agriculture, agribusiness, biotechnology, health, education etc, he added..He continued, this is what Nigeria lacks but so desperately needs at the moment so that we can have a knowledge-based economy, commodity-based economy such as the one we currently operate does not get any country anywhere in terms of national development.

To buttress his point of view on the bill Mohammed sited example of South Korea, which developed an innovation-based economy and is not up to the size of a state in the Soviet Union, has about the economic size of the Soviet Union. China, Japan and India which are global economic giants do not have a drop of oil. India for instance rakes in a whopping 140 billion USD annually from ICT-based solutions and services.

This is just an inkling of what can be achieved through innovation. The Swedish Innovation Agency champions and coordinates innovation-based activities in Sweden for national development. The Thailand Innovation Agency plays a similar role in Thailand. The list is endless; virtually every country in the world has an Agency whose mandate is the coordination of innovation for national development.

In view of the crucial and critical role the National Innovation Agency will play in re-tooling our national economy for national development, we therefore urge the Honourable Speaker of the House of Representatives Rt. Hon Femi Gbajabiamila to please call for the second reading of this Bill and to expedite action for its eventual passage as such an agency will add huge value to Nigeria in terms of wealth creation and overall national competitiveness and development, the group added.

";n.innerHTML="window._taboola = window._taboola || [];_taboola.push({mode:'thumbnails-c', container:'taboola-below-article', placement:'below-article', target_type: 'mix'});window._taboola = window._taboola || [];_taboola.push({mode:'thumbnails-d', container:'taboola-below-article-second', placement:'below-article-2nd', target_type: 'mix'});";insertAfter(t,e);insertAfter(n,t)}injectWidgetByMarker('tbmarker');

Follow this link:
Northern youth group seeks speedy passage of Bill to establish National Innovation agency - Daily Sun

Global Healthcare Nanotechnology (Nanomedicine) Market Analysis, Size, Share, Growth, Trends and Forecast to 2025 – Express Journal

Posted on July 9, 2020 by Prof Baldwin

Growing at a steady pace, this Healthcare Nanotechnology (Nanomedicine) market research values the industry size in USD million terms for 2020 and expected USD million value by the end of 2025 is provided for decision makers and stakeholders interested in Healthcare Nanotechnology (Nanomedicine) market. The report on Healthcare Nanotechnology (Nanomedicine) market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.

The Healthcare Nanotechnology (Nanomedicine) market research report provides a thorough analysis regarding the production and the consumption patterns of this industry vertical. Based on production aspect, the study offers crucial insights pertaining to the manufacturing patterns of the items, revenue share, and its respective impact on the overall gross margins of the producers.

As per consumption patterns, the document assesses the consumption value and volume regarding each of the product offerings, their sale prices and import & export conditions across various regions listed. Additionally, the report also delivers production and consumption expectations, during the ongoing COVID-19 pandemic.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/140120

Emphasizing on the regional landscape:

Summarizing the product landscape:

Elaborating on the application space:

Highlighting the competitive dynamics:

Briefly, the Healthcare Nanotechnology (Nanomedicine) market research report comprises of a granular assessment regarding the upstream raw materials, downstream buyers, manufacturing equipment and distribution channels. Furthermore, it evaluates the various market dynamics such as opportunities, trends, drivers and limitations & challenges which are impacting the revenue generation of the overall market.

Key Questions Answered in Global Healthcare Nanotechnology (Nanomedicine) market Report: -

The Report Provides The Following Information:

Categorize data at the regional level as well as revenue and growth of in these regions

Distribution channels, and consumption patterns, of the global Healthcare Nanotechnology (Nanomedicine) market

Study data of the market on the basis of the country, including market share and revenue of the important countries

Critical analysis of every market player, such as collaborations, acquisitions, and product launches

Market opportunities, challenges, and threats faced by the vendors in the global Healthcare Nanotechnology (Nanomedicine) market are highlighted

Upstream raw materials and manufacturing equipment are investigated.

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/140120

View original post here:
Global Healthcare Nanotechnology (Nanomedicine) Market Analysis, Size, Share, Growth, Trends and Forecast to 2025 - Express Journal

Study Says Prior Infection Could Prevent Reinfection, Other COVID-19 News – Bio-IT World

Posted on July 10, 2020 by Prof Baldwin

July 10, 2020 |Animal models are showing how prior infection of the SARS-CoV-2 virus can provide protection against reinfection. Elsewhere, a coronavirus task force task force is examining genes associated with COVID-19 immune response by collecting samples from Japanese patients. This, plus more, are featured in this weeks COVID-19 news from the biotech and research industries.

Literature Updates

Using an animal model for COVID-19, scientists at the University of Wisconsin-Madison, the University of Tokyoand the Icahn School of Medicine at Mount Sinaishow that prior infection with the SARS-CoV-2 virus provides protection against reinfection, and treatment with convalescent serum limits virus replication in their lungs. The study, published in the Proceedings of the National Academy of Sciences, point to the usefulness of Syrian hamsters in trying to understand SARS-CoV-2and in evaluating vaccines, treatments and drugs against the disease it causes. Expanding on earlier work with the animals, researchers demonstrated that both low and high doses of the virus, from patient samples collected in the U.S. and Japan, replicate well in the airways of juvenile and adult hamsters and that the virus can infect both the upper and lower respiratory tracts. The research team also showed that SARS-CoV-2 causes severe disease in the lungs of infected animals, including lesions and the kind of "ground glass" appearance often found in lung scans in human patients. Scans additionally revealed a region of gas in the cavity surrounding the hamster's lungs, indicating severe lung damage. The most severe effects were observed within eight days after infection, and improvement by 10 days. DOI: 10.1073/pnas.2009799117

Researchers at the University of Torontoand National Jewish Health(Denver) have made a drug discovery that shows promise in fighting acute respiratory illnesses such as COVID-19. Called TAT CARMIL1, the "drug" is a combination of two naturally occurring peptides that together penetrate a cell's membrane to douse cytokine storms if deployed early enough. In its first ex vivo study, published in Cell Reports, the peptide duo reduced collagen degradation by up to 43%. It effectively blocks a family of cytokines, called interleukin1, from signaling and reproducing in vast quantities. It precisely targets two receptors, sticking to both the cell's surface and its cell substrate, where it adheres to other cells. Researchers believe the unusual nature of this pathway might restrict its side effects, making TAT CARMIL1 an unusually strong candidate as a potential drug. DOI: 10.1016/j.celrep.2020.107781

An international team of scientists has shown that the G614 variant of the SARS-CoV-2 virus came to dominate cases of COBID-19 around the world by mid-March. Its spike protein differs slightly from the D614 variant, helping the virus copy itself rather than making the virus more deadly(as was initially reported). The study, published in Cell, was led by scientists at Duke University, Los Alamos National Laboratoryand La Jolla Institute(headquarters for the Coronavirus Immunotherapy Consortium). Based on experiments with samples from six San Diego residents, researchers showed that the human immune response could neutralize the new G virus as well or better than the original D virusa finding in line with what doctors saw in COVID-19 patients. DOI: 10.1016/j.cell.2020.06.043

Scientists from theUniversity of South Florida Health(USF Health) Morsani College of Medicine and theUniversity of ArizonaCollege of Pharmacy report in Cell Researchthat theyve identified several existing compounds that block replication of the COVID-19 virus within human cells grown in the laboratory. The inhibitors all demonstrated potent chemical and structural interactions with the SARS-CoV-2 main protease that is critical to the virus's ability to proliferate and has already been validated as an antiviral drug target for genetically similar SARS and MERS. The most promising drug candidates include the FDA-approved hepatitis C medication boceprevirand an investigational veterinary antiviral drug known as GC-376. Calpain inhibitors II and XII, cysteine inhibitors investigated in the past for cancer, neurodegenerative diseases and other conditions, also showed strong antiviral activity. DOI: 10.1038/s41422-020-0356-z

Two recent papers (in Langmuirand ACS Nano) describe a membrane on a chipthat allows continuous monitoring of how drugs and infectious agents interact with human cells. With funding from the U.S. Defense Research Projects Agency, the device will now be used to test potential drug candidates for COVID-19 using virus membranes identical to the SARS-CoV-2 membrane, but which don't contain the viral nucleic acid. The device was developed by researchers from the University of Cambridge, Cornell University andStanford Universityand can mimic any cell type. Their research recently pivoted to how COVID-19 attacks human cell membranes and how it can be blocked. The device, which uses an electronic chip to measure any changes in an overlying membrane extracted from a cell, has been successfully used to monitor the activity of ion channelsthe target of more than 60% of approved pharmaceuticals. It can be as small as the size of a human cell and easily fabricated in arrays. The method is compatible with high-throughput screening and would reduce the number of false positives making it through into the R&D pipeline. DOI: 10.1021/acs.langmuir.0c00804

A researcher at St. Petersburg State University(Russia) has advanced a hypothesis that the severe course of COVID-19 may be associated with von Willebrand factor(VWF), one of the main components of the blood coagulation system. As she explains it, replication of the virus stimulates the development of microdamage on vessel walls that prompts the body to release VWF into the blood to patch possible holes. This increases the risk of thromboses, which has been associated with a significant number of deaths from COVID-19. Different levels of VWF in the blood of patients may explain why infection can happen in completely different ways person to person. VWF levels also differ markedly among healthy peoplee.g., higher among African Americans than Europeans, in men than in women, in adults than in children, and in the elderly than in middle-aged peopleand also appear to be higher among those in blood group A and lower among those in blood group O. The article published in Ecological Genetics. DOI: 10.17816/ecogen33973

Researchers from the University of Houstonand Medistar Corporationreport in Materials Today Physicsthat they have designed a "catch and kill" nickel foam air filter that can trap the virusresponsible for COVID-19, killing it instantly. In testing at the Galveston National Laboratory, run by theUniversity of TexasMedical Branch, they found 99.8% of SARS-CoV-2 was killed in a single pass through the filter when heated to 392 degrees Fahrenheit. It is reportedly compatible with conventional heating, ventilation and air conditioning systems. High-priority venuesincluding hospitals and healthcare facilitieswould be in the initial roll-out of the device. DOI: 10.1016/j.mtphys.2020.100249

Scientists from Germany and Israel have isolated potent SARS-CoV-2 neutralizing antibodieswhich are currently being further characterized and developed together with Boehringer Ingelheim. Theyre expected to enter clinical development later this year. Results, published in Cell,were based on an investigation of the SARS-CoV-2 antibody response in 12 individuals recovered from COVID-19. Of the 255 antibodies reconstructed in the laboratory, 28 neutralizing antibodies were found. SARS-CoV-2-specific B cells carry similar antibody characteristics to those of SARS-CoV-2 neutralizing antibodies, they say, suggesting they can be readily formed and that an active vaccine may provide rapid protection. The antibodies have been developed for protecting against and treating COVID-19 and could also be used for post-exposure prophylaxis. DOI: 10.1016/j.cell.2020.06.044

A researcher at Virginia Tech and two colleagues at the National Institutes of Healthhave found that Bacille Calmette-Gurin (BCG)a tuberculosis vaccineroutinely given to children in countries with high rates of TB infectionmight play a significant role in mitigating mortality rates from COVID-19. Countries with higher rates of BCG vaccinations also had lower peak mortality rates from COVID-19, and the correlation held even after adjusting for variables such as income, access to education and health services, population size and densities, and age distribution. One sample that stood out was Germany, which had different vaccine plans prior to the country's unification in 1990 that has left older Germans (the population most at risk from COVID-19) in the country's eastern states better protected from the current pandemic than their peers in western German states where mortality rates are 2.9 times higher. The BCG vaccines have already been shown to provide broad cross-protections for several viral respiratory illnesses in addition to TB. Researchers stress that the findings are preliminary. The World Health Organization doesnt currently recommend BCG vaccinations for the prevention of COVID-19, but clinical trials are underway to establish whether it confers protection. Their work has published in the Proceedings of the National Academy of Sciences. Article

Using data covering a longer period than previously reported, researchers report in The Journals of Gerontologythat ApoE e4e4 genotype is associated with COVID-19 test positivityat genome-wide significance in the UK Biobank. Similarly, the e4e4 genotype was associated with a four-fold increase in mortality after testing positive for COVID-19. The findings demonstrate that risks for COVID-19 mortality are not simply related to advanced chronological age or the comorbidities commonly seen in aging. DOI: 10.1093/gerona/glaa169

Updates from Industry

A joint research Coronavirus Task Forcehas been established by researchers from eight leading universities and medical institutions in Japan. The task force will examine genes associated with COVID-19 immune response by collecting samples from Japanese patients and apply the findings to development of a mucosal vaccine and predictive modeling for COVID-19 treatment. Its focus is on the fact that the number of COVID-19 deaths per capita among Japanese people is far fewer than those in Western countries. By comparing severe and mild/asymptomatic cases among Japanese people, the group will search for genetic susceptibilities unique to Japanese people associated with exacerbation of COVID-19. As of June 15, collection of patient samples had already begun at 30 facilities, with 60 more awaiting approval from a research ethics committee to start their own large-scale sample collection. The research team plans to collect 600 blood samples from its joint research institutes and use them to conduct comprehensive analyses. After identifying the genes involved in disease exacerbation in Japanese patients, they will try to identify candidate antigens for SARS-CoV-2 using supercomputer simulations. Vaccine efforts will use proprietary molecular needle technology. The goal is to analyze the human genes of samples collected in July and compile results by September. Press release.

The Innovation Center of NanoMedicine(iCONM) has initiated a collaborative study with the Tokyo Metropolitan Institute of Medical Science (TMIMS), aiming to rapidly develop an mRNA vaccinein preparation for the re-pandemic of COVID-19 and attacks by other new coronaviruses. The study will adapt iCONM's basic technologyan mRNA-loaded smart nanomachinesto the TMIMS's expertise in recombinant vaccine discovery. Press release.

The rest is here:
Study Says Prior Infection Could Prevent Reinfection, Other COVID-19 News - Bio-IT World

Nanomedicine Market Is New Business Opportunities and Investment Research Report by 2026 – 3rd Watch News

Posted on July 4, 2020 by Prof Baldwin

UPDATE AVAILABLE ON-DEMAND

Nanomedicine is an application of nanotechnology that deals in the prevention & treatment of diseases in humans. This technology uses submicrometer-sized particles for diagnosis, treatment, and prevention of diseases. Nanomedicines are advantageous over generic drugs in several aspects such as, to reduce renal excretion, improve the ability of drugs to accumulate at pathological sites, and enhance the therapeutic index of drugs. Thus, nanomedicine is used in a wide range of applications that include aerospace materials, cosmetics, and medicine.

The global nanomedicine market was valued at $111,912 million in 2016, and is projected to reach $261,063 million by 2023, growing at a CAGR of 12.6% from 2017 to 2023. The drug delivery segment accounted for nearly two-fifths share of the global market in 2016.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2021

The global market is driven by increase in the development of nanotechnology-based drugs, advantages of nanomedicine in various healthcare applications, and growth in need of therapies with fewer side effects. However, long approval process and risks associated with nanomedicine (environmental impacts) restrain the market growth. In addition, growth of healthcare facilities in emerging economies is anticipated to provide numerous opportunities for the market growth.

The vaccines segment is expected to register a significant CAGR of 13.2% throughout the forecast period. The treatment segment accounted for about fourth-sevenths share in the global market in 2016, accounting for the highest share during the forecast period. This is due to the high demand for therapeutics among patient and rise in the incidence of chronic diseases.

The neurological diseases segment is expected to grow at the highest CAGR of 13.9% during the forecast period, owing to high demand for brain monitoring & treatment devices and drugs. The oncological diseases segment accounted for the highest revenue in 2016, with one-third share of the global market, and is expected to maintain its dominance throughout the forecast period.

In 2016, Asia-Pacific and LAMEA collectively accounted for about one-fourth share of the global market, and is expected to continue this trend due to increased adoption of nanomedicines, especially in China, India, and the other developing economies. In addition, rise in investments by key players in the field of nanomedicines is key driving factor of the Asia-Pacific market.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2021

The Major Key Players Are:

The Other Prominent Players Are:

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

Contact:

David CorreaPortland, OR, United StatesUSA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1(855)550-5975[emailprotected]Web:https://www.alliedmarketresearch.comFollow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

Read this article:
Nanomedicine Market Is New Business Opportunities and Investment Research Report by 2026 - 3rd Watch News

New nanomedicines for mRNA therapeutics in breast cancer and heart failure – Mirage News

Posted on July 6, 2020 by Prof Baldwin

TAU researcher Prof. Dan Peer, from the school of Molecular Cell Biology and Biotechnology, is one of 11 partners in the international project EXPERT that has been awarded a total of 14.9 million EUR from the EU Horizon 2020. The project is working to find efficient ways to deliver protein coding mRNA by using various nanoparticles for the treatment of breast cancer and myocardial infarction, which are two of the most pressing health challenges in European society today.

Prof. Dan Peer, Director, Laboratory of Precision NanoMedicine, School of Molecular Cell Biology and Biotechnology, George S. Wise Faculty of Life Sciences and Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University Center for Nanoscience and Nanotechnology and Tel Aviv University Cancer Biology Research Center.

It is about developing mRNA therapy for the treatment of breast cancer. Much of it involves testing different methods to improve the delivery of mRNA to cells in vivo. These methods are fundamentally based either on lipid nanoparticles (LNPs), biological nanoparticles called exosomes, or cell penetrating peptides (CPPs). In addition to this, we intend to analyze what these nanoparticles bind to in biological fluids in order to better understand what drives uptake in specific cells types.

Our lab was the first to show systemic, cell specific delivery of mRNA molecules that express therapeutic proteins in designated cells. We will further develop our ASSET platform for cell specific targeting of lipid nanoparticles to achieve improved delivery of therapeutic mRNAs and optimize formulations that enable systemic administration in different preclinical models. Part of the work will also consist of understanding how nanoparticle surfaces bind to host factors in blood and how this can affect the uptake of nanoparticles.

We will now see how these delivery methods work side by side in cell culture and animal models. The hope is then to be able to deliver an mRNA cocktail with one of the aforementioned vectors for the treatment of triple-negative breast cancer. In parallel, these vectors will also be evaluated for delivery of VEGF mRNA in the treatment of myocardial infarction.

See the rest here:
New nanomedicines for mRNA therapeutics in breast cancer and heart failure - Mirage News

Global Nanomedicine Market Analysis 2020 With COVID 19 Impact Analysis| Leading Players, Industry Updates, Future Growth, Business Prospects, In-depth…

Posted on June 16, 2020 by Prof Baldwin

Global Nanomedicine Market research report delivers comprehensive analysis of the market structure along with estimations of the various segments and sub-segments of the market. This study also analyzes the market status, market share, growth rate, sales volume, future trends, market drivers, market restraints, revenue generation, opportunities and challenges, risks and entry barriers, sales channels, and distributors. The company profiles of all the chief and dominating market players and brands who are taking steps such as product launches, joint ventures, mergers and acquisitions are mentioned in the report. With the use of SWOT analysis and Porters Five Forces analysis which are two of the standard, prominent and full-proof methods, this Global Nanomedicine Market report is been framed.

To prosper in this competitive market place, businesses consider taking up innovative solutions and market research report is one of them. Analysis and estimations derived through the enormous information gathered in this Global Nanomedicine market analysis report are extremely necessary when it comes to dominating the market or creating a mark in the market as a new emergent. A lot of efforts have been put together and no stone is left unturned while generating this report. This Global Nanomedicine market report represents a professional and all-inclusive study of the industry which focuses on primary and secondary drivers, market share, competitor analysis, leading segments and geographical analysis.

Global nanomedicine marketis registering a healthy CAGR of 15.50% in the forecast period of 2019-2026. This rise in the market value can be attributed to increasing number of applications and wide acceptance of the product globally. There is a significant rise in the number of researches done in this field which accelerate growth of nanomedicine market globally.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanomedicine-market

Key Market Competitors

Few of the major market competitors currently working in the global nanomedicine market are Abbott, Invitae Corporation, General Electric Company, Leadiant Biosciences, Inc., Johnson & Johnson Services, Inc., Mallinckrodt, Merck Sharp & Dohme Corp., NanoSphere Health Sciences, Inc., Pfizer Inc., CELGENE CORPORATION, Teva Pharmaceutical Industries Ltd., Gilead Sciences, Inc., Amgen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Luminex Corporation, Eli Lilly and Company, Nanobiotix, Sanofi, UCB S.A., Ablynx among others.

Competitive Landscape

Global nanomedicine market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of nanomedicine market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

Market Drivers are Restraints

Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/request-a-discount/global-nanomedicine-market

To comprehend Global Nanomedicine market dynamics in the world mainly, the worldwide Nanomedicine market is analyzed across major global regions.

Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.

Some of the Major Highlights of TOC covers:

Chapter 1: Methodology & Scope

Definition and forecast parameters

Methodology and forecast parameters

Data Sources

Chapter 2: Executive Summary

Business trends

Regional trends

Product trends

End-use trends

Chapter 3: Industry Insights

Industry segmentation

Industry landscape

Vendor matrix

Technological and innovation landscape

For More Insights Get Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-nanomedicine-market

Nanomedicine Market report effectively provides required features of the global market for the population and for the business looking people for mergers & acquisitions, making investments, new vendors or concerned in searching for the appreciated global market research facilities. It offers sample on the size, offer, and development rate of the market. The Nanomedicine report provides the complete structure and fundamental overview of the industry market.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

Read the original here:
Global Nanomedicine Market Analysis 2020 With COVID 19 Impact Analysis| Leading Players, Industry Updates, Future Growth, Business Prospects, In-depth...

Trending: Oral Contrast Agent Trends, Key Driven Factors, Segmentation And Forecast To 2020-2026 – Bulletin Line

Posted on June 24, 2020 by Prof Baldwin

LOS ANGELES, United States: QY Research has recently published a report, titled Global Oral Contrast Agent Market Insights and Forecast to 2026. The market research report is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Oral Contrast Agent market. It informs readers about key trends and opportunities in the global Oral Contrast Agent market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global Oral Contrast Agent market.

Key companies operating in the global Oral Contrast Agent market include GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India) Oral Contrast Agent

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1885992/global-oral-contrast-agent-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Oral Contrast Agent market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Oral Contrast Agent Market Segment By Type:

,Barium-based Contrast Media,Iodinated Contrast Media,Gadolinium-based Contrast Media,Microbubble Contrast Media Oral Contrast Agent

Global Oral Contrast Agent Market Segment By Application:

, Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Oral Contrast Agent market.

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1885992/global-oral-contrast-agent-market

TOC

1 Study Coverage1.1 Oral Contrast Agent Product Introduction1.2 Market Segments1.3 Key Oral Contrast Agent Manufacturers Covered: Ranking by Revenue1.4 Market by Type1.4.1 Global Oral Contrast Agent Market Size Growth Rate by Type1.4.2 Barium-based Contrast Media1.4.3 Iodinated Contrast Media1.4.4 Gadolinium-based Contrast Media1.4.5 Microbubble Contrast Media1.5 Market by Application1.5.1 Global Oral Contrast Agent Market Size Growth Rate by Application1.5.2 Cardiovascular Disorders1.5.3 Cancer1.5.4 Gastrointestinal Disorders1.5.5 Musculoskeletal Disorders1.5.6 Neurological Disorders1.5.7 Nephrological Disorders1.6 Study Objectives1.7 Years Considered 2 Executive Summary2.1 Global Oral Contrast Agent Market Size, Estimates and Forecasts2.1.1 Global Oral Contrast Agent Revenue 2015-20262.1.2 Global Oral Contrast Agent Sales 2015-20262.2 Global Oral Contrast Agent, Market Size by Producing Regions: 2015 VS 2020 VS 20262.2.1 Global Oral Contrast Agent Retrospective Market Scenario in Sales by Region: 2015-20202.2.2 Global Oral Contrast Agent Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Oral Contrast Agent Competitor Landscape by Players3.1 Oral Contrast Agent Sales by Manufacturers3.1.1 Oral Contrast Agent Sales by Manufacturers (2015-2020)3.1.2 Oral Contrast Agent Sales Market Share by Manufacturers (2015-2020)3.2 Oral Contrast Agent Revenue by Manufacturers3.2.1 Oral Contrast Agent Revenue by Manufacturers (2015-2020)3.2.2 Oral Contrast Agent Revenue Share by Manufacturers (2015-2020)3.2.3 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI) (2015-2020)3.2.4 Global Top 10 and Top 5 Companies by Oral Contrast Agent Revenue in 20193.2.5 Global Oral Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Oral Contrast Agent Price by Manufacturers3.4 Oral Contrast Agent Manufacturing Base Distribution, Product Types3.4.1 Oral Contrast Agent Manufacturers Manufacturing Base Distribution, Headquarters3.4.2 Manufacturers Oral Contrast Agent Product Type3.4.3 Date of International Manufacturers Enter into Oral Contrast Agent Market3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026)4.1 Global Oral Contrast Agent Market Size by Type (2015-2020)4.1.1 Global Oral Contrast Agent Sales by Type (2015-2020)4.1.2 Global Oral Contrast Agent Revenue by Type (2015-2020)4.1.3 Oral Contrast Agent Average Selling Price (ASP) by Type (2015-2026)4.2 Global Oral Contrast Agent Market Size Forecast by Type (2021-2026)4.2.1 Global Oral Contrast Agent Sales Forecast by Type (2021-2026)4.2.2 Global Oral Contrast Agent Revenue Forecast by Type (2021-2026)4.2.3 Oral Contrast Agent Average Selling Price (ASP) Forecast by Type (2021-2026)4.3 Global Oral Contrast Agent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026)5.1 Global Oral Contrast Agent Market Size by Application (2015-2020)5.1.1 Global Oral Contrast Agent Sales by Application (2015-2020)5.1.2 Global Oral Contrast Agent Revenue by Application (2015-2020)5.1.3 Oral Contrast Agent Price by Application (2015-2020)5.2 Oral Contrast Agent Market Size Forecast by Application (2021-2026)5.2.1 Global Oral Contrast Agent Sales Forecast by Application (2021-2026)5.2.2 Global Oral Contrast Agent Revenue Forecast by Application (2021-2026)5.2.3 Global Oral Contrast Agent Price Forecast by Application (2021-2026) 6 North America6.1 North America Oral Contrast Agent by Country6.1.1 North America Oral Contrast Agent Sales by Country6.1.2 North America Oral Contrast Agent Revenue by Country6.1.3 U.S.6.1.4 Canada6.2 North America Oral Contrast Agent Market Facts & Figures by Type6.3 North America Oral Contrast Agent Market Facts & Figures by Application 7 Europe7.1 Europe Oral Contrast Agent by Country7.1.1 Europe Oral Contrast Agent Sales by Country7.1.2 Europe Oral Contrast Agent Revenue by Country7.1.3 Germany7.1.4 France7.1.5 U.K.7.1.6 Italy7.1.7 Russia7.2 Europe Oral Contrast Agent Market Facts & Figures by Type7.3 Europe Oral Contrast Agent Market Facts & Figures by Application 8 Asia Pacific8.1 Asia Pacific Oral Contrast Agent by Region8.1.1 Asia Pacific Oral Contrast Agent Sales by Region8.1.2 Asia Pacific Oral Contrast Agent Revenue by Region8.1.3 China8.1.4 Japan8.1.5 South Korea8.1.6 India8.1.7 Australia8.1.8 Taiwan8.1.9 Indonesia8.1.10 Thailand8.1.11 Malaysia8.1.12 Philippines8.1.13 Vietnam8.2 Asia Pacific Oral Contrast Agent Market Facts & Figures by Type8.3 Asia Pacific Oral Contrast Agent Market Facts & Figures by Application 9 Latin America9.1 Latin America Oral Contrast Agent by Country9.1.1 Latin America Oral Contrast Agent Sales by Country9.1.2 Latin America Oral Contrast Agent Revenue by Country9.1.3 Mexico9.1.4 Brazil9.1.5 Argentina9.2 Central & South America Oral Contrast Agent Market Facts & Figures by Type9.3 Central & South America Oral Contrast Agent Market Facts & Figures by Application 10 Middle East and Africa10.1 Middle East and Africa Oral Contrast Agent by Country10.1.1 Middle East and Africa Oral Contrast Agent Sales by Country10.1.2 Middle East and Africa Oral Contrast Agent Revenue by Country10.1.3 Turkey10.1.4 Saudi Arabia10.1.5 U.A.E10.2 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Type10.3 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Application 11 Company Profiles11.1 GE Healthcare (US)11.1.1 GE Healthcare (US) Corporation Information11.1.2 GE Healthcare (US) Description and Business Overview11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)11.1.4 GE Healthcare (US) Oral Contrast Agent Products Offered11.1.5 GE Healthcare (US) Related Developments11.2 Bracco Imaging (Italy)11.2.1 Bracco Imaging (Italy) Corporation Information11.2.2 Bracco Imaging (Italy) Description and Business Overview11.2.3 Bracco Imaging (Italy) Sales, Revenue and Gross Margin (2015-2020)11.2.4 Bracco Imaging (Italy) Oral Contrast Agent Products Offered11.2.5 Bracco Imaging (Italy) Related Developments11.3 Bayer HealthCare (Germany)11.3.1 Bayer HealthCare (Germany) Corporation Information11.3.2 Bayer HealthCare (Germany) Description and Business Overview11.3.3 Bayer HealthCare (Germany) Sales, Revenue and Gross Margin (2015-2020)11.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Products Offered11.3.5 Bayer HealthCare (Germany) Related Developments11.4 Guerbet (France)11.4.1 Guerbet (France) Corporation Information11.4.2 Guerbet (France) Description and Business Overview11.4.3 Guerbet (France) Sales, Revenue and Gross Margin (2015-2020)11.4.4 Guerbet (France) Oral Contrast Agent Products Offered11.4.5 Guerbet (France) Related Developments11.5 Lantheus (US)11.5.1 Lantheus (US) Corporation Information11.5.2 Lantheus (US) Description and Business Overview11.5.3 Lantheus (US) Sales, Revenue and Gross Margin (2015-2020)11.5.4 Lantheus (US) Oral Contrast Agent Products Offered11.5.5 Lantheus (US) Related Developments11.6 Daiichi Sankyo (Japan)11.6.1 Daiichi Sankyo (Japan) Corporation Information11.6.2 Daiichi Sankyo (Japan) Description and Business Overview11.6.3 Daiichi Sankyo (Japan) Sales, Revenue and Gross Margin (2015-2020)11.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Products Offered11.6.5 Daiichi Sankyo (Japan) Related Developments11.7 Unijules Life Sciences (India)11.7.1 Unijules Life Sciences (India) Corporation Information11.7.2 Unijules Life Sciences (India) Description and Business Overview11.7.3 Unijules Life Sciences (India) Sales, Revenue and Gross Margin (2015-2020)11.7.4 Unijules Life Sciences (India) Oral Contrast Agent Products Offered11.7.5 Unijules Life Sciences (India) Related Developments11.8 J.B. Chemicals and Pharmaceuticals (India)11.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information11.8.2 J.B. Chemicals and Pharmaceuticals (India) Description and Business Overview11.8.3 J.B. Chemicals and Pharmaceuticals (India) Sales, Revenue and Gross Margin (2015-2020)11.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Products Offered11.8.5 J.B. Chemicals and Pharmaceuticals (India) Related Developments11.9 Spago Nanomedicine (Sweden)11.9.1 Spago Nanomedicine (Sweden) Corporation Information11.9.2 Spago Nanomedicine (Sweden) Description and Business Overview11.9.3 Spago Nanomedicine (Sweden) Sales, Revenue and Gross Margin (2015-2020)11.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Products Offered11.9.5 Spago Nanomedicine (Sweden) Related Developments11.10 Taejoon Pharm (South Korea)11.10.1 Taejoon Pharm (South Korea) Corporation Information11.10.2 Taejoon Pharm (South Korea) Description and Business Overview11.10.3 Taejoon Pharm (South Korea) Sales, Revenue and Gross Margin (2015-2020)11.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Products Offered11.10.5 Taejoon Pharm (South Korea) Related Developments11.1 GE Healthcare (US)11.1.1 GE Healthcare (US) Corporation Information11.1.2 GE Healthcare (US) Description and Business Overview11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)11.1.4 GE Healthcare (US) Oral Contrast Agent Products Offered11.1.5 GE Healthcare (US) Related Developments11.12 Magnus Health (India)11.12.1 Magnus Health (India) Corporation Information11.12.2 Magnus Health (India) Description and Business Overview11.12.3 Magnus Health (India) Sales, Revenue and Gross Margin (2015-2020)11.12.4 Magnus Health (India) Products Offered11.12.5 Magnus Health (India) Related Developments 12 Future Forecast by Regions (Countries) (2021-2026)12.1 Oral Contrast Agent Market Estimates and Projections by Region12.1.1 Global Oral Contrast Agent Sales Forecast by Regions 2021-202612.1.2 Global Oral Contrast Agent Revenue Forecast by Regions 2021-202612.2 North America Oral Contrast Agent Market Size Forecast (2021-2026)12.2.1 North America: Oral Contrast Agent Sales Forecast (2021-2026)12.2.2 North America: Oral Contrast Agent Revenue Forecast (2021-2026)12.2.3 North America: Oral Contrast Agent Market Size Forecast by Country (2021-2026)12.3 Europe Oral Contrast Agent Market Size Forecast (2021-2026)12.3.1 Europe: Oral Contrast Agent Sales Forecast (2021-2026)12.3.2 Europe: Oral Contrast Agent Revenue Forecast (2021-2026)12.3.3 Europe: Oral Contrast Agent Market Size Forecast by Country (2021-2026)12.4 Asia Pacific Oral Contrast Agent Market Size Forecast (2021-2026)12.4.1 Asia Pacific: Oral Contrast Agent Sales Forecast (2021-2026)12.4.2 Asia Pacific: Oral Contrast Agent Revenue Forecast (2021-2026)12.4.3 Asia Pacific: Oral Contrast Agent Market Size Forecast by Region (2021-2026)12.5 Latin America Oral Contrast Agent Market Size Forecast (2021-2026)12.5.1 Latin America: Oral Contrast Agent Sales Forecast (2021-2026)12.5.2 Latin America: Oral Contrast Agent Revenue Forecast (2021-2026)12.5.3 Latin America: Oral Contrast Agent Market Size Forecast by Country (2021-2026)12.6 Middle East and Africa Oral Contrast Agent Market Size Forecast (2021-2026)12.6.1 Middle East and Africa: Oral Contrast Agent Sales Forecast (2021-2026)12.6.2 Middle East and Africa: Oral Contrast Agent Revenue Forecast (2021-2026)12.6.3 Middle East and Africa: Oral Contrast Agent Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis13.1 Market Opportunities and Drivers13.2 Market Challenges13.3 Market Risks/Restraints13.4 Porters Five Forces Analysis13.5 Primary Interviews with Key Oral Contrast Agent Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis14.1 Value Chain Analysis14.2 Oral Contrast Agent Customers14.3 Sales Channels Analysis14.3.1 Sales Channels14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix16.1 Research Methodology16.1.1 Methodology/Research Approach16.1.2 Data Source16.2 Author Details16.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Nanomedicine Market Revenue Value(USD Mn), New Business Strategies and CAGR Forecast 2029 – News Monitoring

Posted on July 4, 2020 by Prof Baldwin

The research study Global Nanomedicine Industry provides strategic appraisal of the Nanomedicine market. Our expedition specialists acutely determine the momentous aspects of the Global Nanomedicine report. It also offers a detail valuation with respect to the future technologies relying on the historical data and present circumstance of Nanomedicine market situation. In this Nanomedicine report, we have examined the principals, manufacturers in the market, geographical regions, product type, and Nanomedicine market end-client applications. The global Nanomedicine report comprises of primary and secondary information which is epitomized in the form of pie- charts, tables, Nanomedicine analytical diagrams, and reference figures. The Nanomedicine report is presented in a competent way, that involves basic patois, basic Nanomedicine overview, agreements, and certain facts as per consolation and comprehension.

For Better Understanding, Request A Free Pdf Sample Copy Of Nanomedicine Market Here@ https://marketresearch.biz/report/nanomedicine-market/request-sample

(***Our FREE SAMPLE COPY of the report offers a quick advent to the studies report outlook, TOC, a listing of tables and figures, an outlook to key players of the market and comprising key regions.)

Additionally, in-depth business outline, Nanomedicine market revenue study, strategies, and SWOT analysis of the top players have been provided in the report. Players in the Global Nanomedicine market are directing to vast their operations to leading regions. Further, Nanomedicine market companies are concentrate on innovation and establishing their products at competitive prices. A detail Nanomedicine supply chain study in the report will give Nanomedicine readers a better understanding.

Furthermore, the worldwide Nanomedicine market report describe segment-wise bifurcation in a way to offer the actual landscaping analogous to the market situation. The global Nanomedicine market is classified into product, application, and region with outstanding market players Pfizer Inc., Merck & Co., Ablynx NV, Nanosphere, Celgene Corporation, Abraxis BioScience, Inc., Teva Pharmaceutical Industries Limited, Inc., Abbott Laboratories, Johnson & Johnson Services, GE Healthcare Limited, Inc. and Inc..

Download Now And Browse Complete Information On The COVID 19 Impact Analysis On Nanomedicine Market:https://marketresearch.biz/report/nanomedicine-market/covid-19-impact

***NOTE: As the world is experiencing the impact of Coronavirus, the MarketResearch.Biz has up to date its global Nanomedicine market research report. Our Team of Industry Researchers are Studying Covid19 and its Impact on Nanomedicine Market Growth and wherever necessary we will be considering Covid19 Footmark for Better Analysis of Market and Industries. Congenially get in Touch for More Details Information.

Market Segmentation:

Global nanomedicine market segmentation by product: Therapeutics, Regenerative medicine, In-vitro diagnostics, In-vivo diagnostics, Vaccines. Global nanomedicine market segmentation by application: Clinical Oncology, Infectious diseases, Clinical Cardiology, Orthopedics, Others

Moving ahead, the Nanomedicine market is influencing the North America market that contains (United States, Canada, and Mexico), Nanomedicine market is growing in Europe market (France, Germany, Italy, UK, and Russia), witnessed growth in the Asia Pacific region (Japan, China Korea, South East Asia and India), followed by Nanomedicine market in South America (Argentina, Columbia and Brazil), and the Middle East and Africa (UAE, Saudi Arabia, Nigeria, Egypt and South Africa).

The global Nanomedicine market reports confront the ebb and flow involved in significant market players. Several Nanomedicine movement, processes, basics, and knowledge are provided in the researching study, that ease our readers to understand the market and can differentiate with the other Nanomedicine market contenders, as well guide in taking an correct decision with regards to Nanomedicine future expectation.

Any Query? Feel Free To Inquire Here: https://marketresearch.biz/report/nanomedicine-market/#inquiry

The data is impersonated from different sites, journals, magazines, research papers and yearly reports from Nanomedicine industries and gathered for advanced judgment. Validation of information is done by carrying out face-to-face interviews with fundamental conclusion experts and pioneers of Nanomedicine industry. Later, it is represented in form of graphs, tables and Nanomedicine market pie-diagrams.

The global Nanomedicine market has been well arranging in 15 chapters:

Chapter 1, Serves the complete assessment of the global Nanomedicine market, risk, mergers and collaboration, product classifications.

Chapter 2, Correlate with the key companies their supply-demand ratio relevant to Nanomedicine raw materials, price format, company revenue and sales.

Chapter 3, Nanomedicine market report disclose geological analysis in terms of income and sales forecasted period 2017-2026.

Chapter 4, The Nanomedicine report focuses on top driving organizations in the growing regions alongside their benefit, agreements, and market volume from 2017 to 2026.

Chapter 5,6,7, an In-sight study of the Nanomedicine market, related to top countries that give sales and revenue contribution in the market.

Chapter 8 and 9, the global Nanomedicine market explore this market through different segments, by product type, end-user applications, their market value, and growth rate.

Chapter 10 and 11, describes the Nanomedicine market circumstances over the forecast period for product type, end-client application, and regional study from 2017 to 2026.

Chapter 13,14 and 15, reveals the processed used in collecting the data, Nanomedicine market overview, different techniques used in the process of research findings, assumptions, appendix and various assets.

Get Complete Table Of Content: https://marketresearch.biz/report/nanomedicine-market/#toc

Altogether, the global Nanomedicine report conducts an extensive investigation of the parent market, to know the overall of the global Nanomedicine market. Moreover, key players guiding the global Nanomedicine market over the market dimension, product scope, strategies, distinct Nanomedicine applications respecting to the market, product type along with the global market detailing and Nanomedicine advance prospects.

About Us:

MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge.We offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.

Mr. Benni Johnson

Prudour Pvt. Ltd.

420 Lexington Avenue,

Suite 300 New York City, NY 10170,

United States

Tel: + 1-347-826-1876

Email ID: inquiry@marketresearch.biz

Website: https://marketresearch.biz/

View original post here:
Nanomedicine Market Revenue Value(USD Mn), New Business Strategies and CAGR Forecast 2029 - News Monitoring

Iron Nanorobots Go Undercover to Track Living Cells Inside the Body – SciTechDaily

Posted on June 5, 2020 by Prof Baldwin

Labeled cells could be tracked either in cell cultures or once injected into a living animal. Credit: 2020 KAUST

Customizable magnetic iron nanowires pinpoint and track the movements of target cells.

Living cells inside the body could be placed under surveillancetheir location and migration noninvasively tracked in real time over many daysusing a new method developed by researchers at KAUST.

The technique uses magnetic core-shell iron nanowires as nontoxic contrast agents, which can be implanted into live cells, lighting up those cells location inside a living organism when scanned by magnetic resonance imaging (MRI). The technique could have applications ranging from studying and treating cancer to tracking live-cell medical treatments, such as stem cell therapies.

Jrgen Kosel and his team recently showed that core-shell iron nanowires could selectively kill cancer cells with a combination attack, delivering an anticancer drug into target cells while also puncturing the cells membrane and unleashing blasts of heat. Now, in collaboration with researchers from the CIC biomaGUNE in San Sebastian, Spain, the team has shown that the same type of iron core, iron-oxide shell nanowires, can be used for noninvasive medical imaging. The nanowires could potentially be used as theranostic agents, able to identify, track and then take out target cells.

Cell labeling and tracking has become an invaluable tool for scientific and clinical applications, says Aldo Martinez-Banderas, a Ph.D. student in Kosels team. One of the key aspects of cell tracking studies is the sensitivity to detect a small number of cells after implantation, so the strong magnetization and biocompatibility of our nanowires are advantageous characteristics for MRI tracking.

The nanowires performed well as MRI contrast agents, even at very low concentrations, and the magnetic response could be tuned by altering the thickness of the nanowire shell, the team showed. The nanowires biocompatibility permitted long-term tracking of the live cells. The nanowires interacted with cells without compromising their survival, functionality or capacity to proliferate, Martinez-Banderas explains. The labeled cells could be tracked either in cell cultures or once injected into a living animal. The strong magnetization of the nanowires enabled the detection of approximately 10 labeled cells within the brain of a mouse for a period of at least 40 days, which allowed us to trace their exact location and fate in the animal, Martinez-Banderas says.

These core-shell nanowires have various additional features, including the ability to control them magnetically to guide them to a particular location, to carry drugs, or be to heated with a laser, Kosel says. Combining all of that with the capability of tracking creates a theranostic platform that can open the door for very promising new approaches in nanomedicine.

Reference: Magnetic coreshell nanowires as MRI contrast agents for cell tracking by Aldo Isaac Martnez-Banderas, Antonio Aires, Sandra Plaza-Garca, Lorena Cols, Julin A. Moreno, Timothy Ravasi, Jasmeen S. Merzaban, Pedro Ramos-Cabrer, Aitziber L. Cortajarena and Jrgen Kosel, 12 March 2020, Journal of Nanobiotechnology.DOI: 10.1186/s12951-020-00597-3

See the rest here:
Iron Nanorobots Go Undercover to Track Living Cells Inside the Body - SciTechDaily

Nano-Medical Device Market 2027 : Which region will gain the largest growth? – Cole of Duty

Posted on June 5, 2020 by Prof Baldwin

The report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

Nanomedicine is the medical application of nanotechnology, and it ranges from the medicinal uses of nanomaterials and biological devices to nano electronic biosensors. However, current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials (materials whose structure is on the scale of nanometers, i.e., billionths of a meter). Also, functionalities can be added to nanomaterials by interfacing them with biological molecules or structures. Thus far, the integration of nanomaterials with biology has led to the development of diagnostic devices, contrast agents, analytical tools, physical therapy applications, and drug delivery vehicles.

Download a Sample Report Explore further @ https://www.theinsightpartners.com/sample/TIPRE00011102/

The nano-medical device market is expected to witness significant growth over the forecast period, due to increasing prevalence of chronic diseases, growing R&D activities. Moreover, rising awareness pertaining to minimally invasive surgical procedures and development of technologically advanced medical devices which are compact, precise and efficient are amongst key factors for the growth of nanomedical devices market over the forecast period.

Key Players Influencing the Market:

1. Affymetrix2. Crucell N.V.3. Flamel Technologies S.A.4. Nektar Therapeutics5. Par Pharmaceutical companies Inc.6. PerkinElmer7. St.Jude Medical8. Starkey Hearing Technologies9. Starpharma Holdings limited10. Stryker Corporation

Market Segmentation :

The nano-medical device market is segmented on the basis of product type, and application. Based on product type, the market is segmented as biochip, implant materials, medical textiles, wound dressing, cardiac rhythm management devices and hearing aid. On the basis of application, the market is categorized as therapeutic, diagnostic and research.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the nano-medical device market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nano-medical device market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting nano-medical device market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nano-medical device market in these regions.

Request for Buy Report @ https://www.theinsightpartners.com/buy/TIPRE00011102/

Reasons to Buy the Report:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

The Insight partners,

Phone: +1-646-491-9876Email:[emailprotected]

Excerpt from:
Nano-Medical Device Market 2027 : Which region will gain the largest growth? - Cole of Duty

Healthcare Nanotechnology (Nanomedicine) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 – Cole of Duty

Posted on May 14, 2020 by Prof Baldwin

Endo International

Moreover, the Healthcare Nanotechnology (Nanomedicine) report offers a detailed analysis of the competitive landscape in terms of regions and the major service providers are also highlighted along with attributes of the market overview, business strategies, financials, developments pertaining as well as the product portfolio of the Healthcare Nanotechnology (Nanomedicine) market. Likewise, this report comprises significant data about market segmentation on the basis of type, application, and regional landscape. The Healthcare Nanotechnology (Nanomedicine) market report also provides a brief analysis of the market opportunities and challenges faced by the leading service provides. This report is specially designed to know accurate market insights and market status.

By Regions:

* North America (The US, Canada, and Mexico)

* Europe (Germany, France, the UK, and Rest of the World)

* Asia Pacific (China, Japan, India, and Rest of Asia Pacific)

* Latin America (Brazil and Rest of Latin America.)

* Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=210503&utm_source=NYH&utm_medium=888

Table of Content

1 Introduction of Healthcare Nanotechnology (Nanomedicine) Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Healthcare Nanotechnology (Nanomedicine) Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Healthcare Nanotechnology (Nanomedicine) Market, By Deployment Model

5.1 Overview

6 Healthcare Nanotechnology (Nanomedicine) Market, By Solution

6.1 Overview

7 Healthcare Nanotechnology (Nanomedicine) Market, By Vertical

7.1 Overview

8 Healthcare Nanotechnology (Nanomedicine) Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Healthcare Nanotechnology (Nanomedicine) Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Get Complete Report

@ https://www.marketresearchintellect.com/need-customization/?rid=210503&utm_source=NYH&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Healthcare Nanotechnology (Nanomedicine) Market Size, Healthcare Nanotechnology (Nanomedicine) Market Trends, Healthcare Nanotechnology (Nanomedicine) Market Growth, Healthcare Nanotechnology (Nanomedicine) Market Forecast, Healthcare Nanotechnology (Nanomedicine) Market Analysis Sarkari result, Government Jobs, Sarkari naukri, NMK, Majhi Naukri,

Our Trending Reports

Fin Tech Blockchain Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Flexible Polyurethane Foam Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Continue reading here:
Healthcare Nanotechnology (Nanomedicine) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Cole of Duty

Clene Nanomedicine Announces Over 50% of Subjects Randomized in RESCUE-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with…

Posted on May 26, 2020 by Prof Baldwin

SALT LAKE CITY, May 26, 2020 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announcedits Australian subsidiary has completed over 50% of participant randomization in the Phase 2 RESCUE-ALS study with its lead nanocatalytic therapy, CNM-Au8, for the treatment of Amyotrophic Lateral Sclerosis (ALS). The RESCUE-ALS study is substantially funded by FightMND.

The randomized, double-blind, multi-center RESCUE-ALS study is an ongoing study evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in early symptomatic ALS patients. The study has to date enrolled 26 subjects of 42 planned participants.

"Enrollment in this Phase 2 study is ahead of schedule and clearly emphasizes the unmet medical need in this devasting disease. In preclinical models of ALS, CNM-Au8 has been shown to promote neuroprotection and reduce neurodegeneration. We believe the unique mechanism of CNM-Au8 provides the potential to be an effective disease-modifying therapy for patients with ALS and we look forward to completing enrollment," said Robert Glanzman, MD, FAAN, Chief Medical Officer of Clene.

"We are excited to achieve this enrollment milestone for our Phase 2 RESCUE-ALS trial and believe we are on track to complete full enrollment in the third quarter of this year," said Rob Etherington, President and CEO of Clene.

About RESCUE-ALS

RESCUE-ALS is Phase 2 multi-center randomized, double-blind, parallel group, placebo-controlled study examining the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in participants who are newly symptomatic ALS (within 24-months of screening or 12-months from diagnosis) and with a clinically probable or possible or definite ALS diagnosis. Enrolled subjects will be randomized 1:1 to receive either active treatment with CNM-Au8 30 mg or placebo in addition to their current standard of care. Participants will receive their randomized oral treatment daily over 36 consecutive weeks during the Treatment Period. The treatment is taken by mouth once daily first thing every morning. The objective of this study is to assess bioenergetic catalysis with CNM-Au8 to slow disease progression in patients with ALS.

About CNM-Au8

CNM-Au8 is a concentrated, aqueous suspension of clean-surfaced faceted nanocrystalline gold (Au) that acts catalytically to support important intracellular biological reactions. CNM-Au8 consists solely of gold atoms organized into faceted, geometrical crystals held in suspension in sodium bicarbonate buffered, pharmaceutical grade water. CNM-Au8 has demonstrated safety in Phase 1 studies in healthy volunteersand both remyelination and neuroprotection effects in multiple preclinical models. Preclinical data presented at scientific congresses demonstrated that treatment with CNM-Au8 in neuronal cultures improved survival of neurons, protected neurite networks, decreased intracellular levels of reactive oxygen species, and improved mitochondrial capacity in response to cellular stress, induced by multiple disease-relevant neurotoxins. Oral treatment with CNM-Au8 improved functional behaviors in a rodent models of ALS, multiple sclerosis, and Parkinson's disease versus vehicle (placebo). CNM-Au8 has received regulatory approval to proceed to clinical studies for the treatment of remyelination failure in patients with multiple sclerosis and neuroprotection in patients with amyotrophic lateral sclerosis(ALS) and Parkinson's disease.

About Amyotrophic Lateral Sclerosis (ALS)

ALS is a universally fatal neurodegenerative disorder that results in loss of motor neurons in the cerebral cortex, brain stem, and spinal cord. ALS, also known as Lou Gehrig's disease, leads to the death of the neurons controlling voluntary muscles resulting in weakness, muscle atrophy, and progressive paralysis. ALS affects more than 15,000 patients in the United States and is the most prevalent adult-onset progressive motor neuron disease.

About Clene

Clene Nanomedicine, Inc. is a privately-held, clinical-stage biopharmaceutical company, focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally-administered neurotherapeutic drugs. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland. For more information, please visit http://www.clene.com.

About FightMND

FightMND is a not-for-profit registered charity, founded in 2014. It was established to raise the awareness of Motor Neurone Disease (MND) in Australia, to increase funding for research to find an effective treatment and cure and to provide care equipment for MND patients. We have a clear objective to a have a world free from MND.

FightMND is Australia's largest independent MND foundation focused on funding large- scale, collaborative research and clinical trials. The generous donations contributed by everyday Australians, right across the country, has enabled FightMND to raise and commit millions to cure and care initiatives.

Investor Contact

Kaitlyn BroscoThe Ruth Group646-536-7032[emailprotected]

Media Contact

Kirsten ThomasThe Ruth Group508-280-6592[emailprotected]

SOURCE Clene Nanomedicine, Inc.

clene.com

Read the original here:
Clene Nanomedicine Announces Over 50% of Subjects Randomized in RESCUE-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with...

NANOBIOTIX Receives the 2019 Prix Galien Award for First-in-Class HENSIFY – Business Wire

Posted on December 20, 2019 by Prof Baldwin

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:

NANOBIOTIX (Paris:NANO) (Euronext: NANO - ISIN: FR0011341205 the Company), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced receipt of the French 2019 Prix Galien Award for Most Innovative MedTech. The Companys lead product, HENSIFY (NBTXR3) brand name for the treatment of locally advanced Soft Tissue Sarcoma (STS), was recognized after receiving European market approval (CE marking, DM class III, on April 2, 2019) earlier this year. The Prix Galien Award recognizes outstanding biomedical and medical technology product achievements that improve the human condition.

HENSIFY is a first-in-class radioenhancer consisting of an aqueous suspension of crystalline hafnium oxide nanoparticles. The product is administered only once, directly into the tumor, before a patients first radiotherapy session. After intratumoral injection, the nanoparticles penetrate the tumor cells and, when activated by ionizing radiation, deliver a larger energy deposit within the tumor where the nanoparticles are present, thereby increasing the tumor-killing effect of treatment without increasing damage to surrounding healthy tissues. HENSIFY has a universal, physical mode of action and is inert within the human body outside of the presence of ionizing radiation.

The product is approved in Europe for the treatment of Soft Tissue Sarcoma (STS). Positive results from the Companys phase III STS study were featured the August 2019 edition of The Lancet Oncology.

Moving forward, the Company is engaged in global clinical development of the product across fifteen (15) clinical trials in STS and other indications with a primary focus on global registration for the treatment of Head and Neck cancers. These trials include the expansion phase of a European phase I evaluating the safety and feasibility of NBTXR3 activated by radiation therapy(Study NBTXR3-102); an immuno-oncology (I/O) basket trial (Study NBTXR3-1100) which evaluates NBTXR3 in combination with anti-PD-1 in the United States (US); phase I trials evaluating NBTXR3 activated by radiation therapy for the treatment of liver and prostate cancer; a partnership with PharmaEngine in Asia evaluating NBTXR3 in combination with cisplatin; and a clinical collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) including nine (9) trials across several indications.

About the PRIX GALIEN

Created in France in 1970, the Prix Galien is the most prestigious award in the field of pharmaceutical research and innovation. Referred to as the Nobel Prize of pharmaceutical research, it recognizes the efforts and achievements of pharmaceutical research and development.

About NBTXR3

NBTXR3 is a first-in-class product designed to destroy tumors through physical cell death when activated by radiotherapy. NBTXR3 has a high degree of biocompatibility, requires one single administration before the first radiotherapy treatment session, and has the ability to fit into current worldwide standards of radiation care. The physical mode of action of NBTXR3 makes it applicable across solid tumors such as lung, prostate, liver, glioblastoma, and breast cancers.

NBTXR3 is actively being evaluated in head and neck cancer with locally advanced squamous cell carcinoma of the oral cavity or oropharynx in elderly and frail patients unable to receive chemotherapy or cetuximab with limited therapeutic options. Promising results have been observed in the phase I/II trial regarding local control. In the United States, the company has started the regulatory process in regard to the clinical authorization to the phase II/III in locally advanced head and neck cancers.

Nanobiotix is also running an Immuno-Oncology development program. The Company received approval FDA to launch a clinical trial of NBTXR3 activated by radiotherapy in combination with anti-PD-1 antibodies in locoregional recurrent (LRR) or recurrent and metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) and lung or liver metastasis (mets) with HNSCC not amenable to re-irradiation or non-small cell lung cancer (NSCLC) as the primary tumor.

The other ongoing NBTXR3 trials are treating patients with liver cancers (hepatocellular carcinoma and liver metastasis), locally advanced or unresectable rectal cancer in combination with chemotherapy, head and neck cancer in combination with concurrent chemotherapy, and prostate adenocarcinoma. Furthermore, the company has a large-scale, comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center (9 new phase I/II clinical trials in the United States) to evaluate NBTXR3 across head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers.

About NANOBIOTIX: http://www.nanobiotix.com

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotixs first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotixs Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Companys headquarters are in Paris, France, with a U.S. affiliate in Cambridge, MA, and European affiliates in Spain and Germany

Disclaimer

This press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the reference document of Nanobiotix registered with the French Financial Markets Authority (Autorit des Marchs Financiers) under number R.19-018 on April 30, 2019 (a copy of which is available on http://www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

See original here:
NANOBIOTIX Receives the 2019 Prix Galien Award for First-in-Class HENSIFY - Business Wire

Select Page ::